Simple blood test may predict head and neck cancer behavior

NCT ID NCT07512921

Recruiting now Knowledge-focused Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Source: ClinicalTrials.gov ↗

First seen May 07, 2026 · Last updated May 26, 2026 · Updated 2 times

Summary

This observational study aims to see if a blood test can identify the same biological subtypes of HPV-negative head and neck cancer that are currently only found by analyzing tumor tissue. About 300 adults with advanced but curable cancer will give blood samples before and after treatment. Researchers will compare gene activity in blood and tumor samples to see if the blood test can reliably predict cancer behavior and outcomes. The study does not test any new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK (HNSCC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Azienda Ospedaliera Universitaria di Sassari
RECRUITING

Sassari, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITING

Milan, 20133, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HEAD AND NECK (HNSCC)